Biogen Inc (BSP:BIIB34)
R$ 169.49 1.36 (0.81%) Market Cap: 149.37 Bil Enterprise Value: 178.06 Bil PE Ratio: 15.80 PB Ratio: 1.56 GF Score: 75/100

Biogen Inc Webcast on ALS Portfolio Corporate Call Transcript

Jun 05, 2019 / 12:00PM GMT
Release Date Price: R$145.1
Operator

Good morning. My name is Jessa, and I will be your conference operator today. At this time, I would like to welcome everyone to the Biogen webcast on ALS portfolio. (Operator Instructions)

I would now like to turn the conference over to Mr. Matt Calistri, Vice President, Investor Relations. You may begin your conference.

Matthew Calistri
Biogen Inc. - Senior Director of IR

Thank you, Jessa. Welcome to today's webcast to review our strategy and R&D progress in amyotrophic lateral sclerosis, or ALS. I want to thank you all for joining us this morning.

Before we begin, I encourage everyone to go to the Investors section of biogen.com to find slides that will accompany the discussion related to this call. I want to point out that we will be making forward-looking statements, which are based on our current expectations and beliefs. These statements are subject to certain risks and uncertainties, and our actual results may differ materially. I encourage you to consult the risk factors discussed in our SEC filings for additional detail.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot